US stocks recovered from losses on Wednesday to close higher on the day. Earnings from Alphabet (GOOG, GOOGL) and AMD (AMD) ...

Proprietary Insights – Stifel Discover delivers exclusive analysis and commentary from Stifel’s Chief Investment Officer, Chief Economist, Chief Washington Policy Strategist, equity research analysts, ...

Stifel Financial (SF) announced the launch of Stifel Discover, a new Stifel-branded content feed available through its Wealth Tracker app. The ...

Stifel Financial is a top pick for long-term growth with solid Q424 results, a 10% dividend hike & solid wealth management ...

Stifel analysts adjusted their outlook on CRISPR Therapeutics (NASDAQ:CRSP), currently trading at $43.09 with a market capitalization of $3.7 billion, reducing the price target to $49 from the ...

Pliant Therapeutics (NASDAQ:PLRX) stock, currently trading at $3.23, maintained a Buy rating and a $32.00 price target from Stifel analysts following recent developments in the company's clinical ...

The outlook differs from other makers of microchips for cars and for industrial use that have missed expectations, in some ...

In addition, GH Research PLC has granted the underwriters a 30-day option to purchase up to an additional 1,500,000 ordinary shares at the public offering price, less underwriting discounts and ...

The outlook differs from other makers of microchips for cars and for industrial use that have missed expectations, in some cases by a wide margin, Juergen Wagner, an analyst from Stifel said.

Stifel Financial Corp. provides securities brokerage ... The Institutional Group segment involves in research, equity and fixed income institutional sales and trading, investment banking, public ...

We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not ...